Cited by 17TGF-β signaling in diseasesProtein Kinase Regulation and GTPase SignalingSignaling Pathways in Disease

Regulation of tumor suppressor PDCD4 by novel protein kinase C isoforms

Open access
Nakashima, Mayumi, Hamajima, Hiroshi, Xia, Jinghe, Iwane, Shinji, Kwaguchi, Yasunori, Eguchi, Yuichiro, Mizuta, Toshihiko, Fujimoto, Kazuma +2 more·2010·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Abstract

Transforming growth factor-beta1 (TGF-beta1) induces apoptosis in normal hepatocytes and hepatoma cells. PDCD4 is involved in TGF-beta1-induced apoptosis via the Smad pathway. The tumor promoter 12-O-tetradecanoylphorbor-13-acetate (TPA), a protein kinase C stimulator, inhibits TGF-beta1-induced apoptosis. However, the mechanisms of TPA action on PDCD4 expression remain to be elucidated. Therefore. the regulatory mechanism of PDCD4 expression by PKC was investigated. The treatment of the human hepatoma cell line, Huh7 with TPA suppressed PDCD4 protein expression and TGF-beta1 failed to increase the PDCD4 protein expression. PKC inhibitors Ro-31-8425 or bisindolylmaleimide-1-hydrocholoride (pan-PKC inhibitors) and rottlerin (PKCdelta inhibitor), but not Go6976 (PKCalpha inhibitor), enhanced the induction of PDCD4 protein by TGF-beta1. Furthermore, siRNA-mediated knockdown of PKCdelta and epsilon, but not PKCalpha, augmented the TGF-beta1-stimulated PDCD4 protein expression. However, TPA or pan-PKC inhibitor did not alter the PDCD4 mRNA expression either under basal- and TGF-beta1-treated conditions. The down-regulation of PDCD4 by TPA was restored by treatment with the proteasome inhibitor MG132. These data suggest that two isoforms of PKCs are involved in the regulation of the PDCD4 protein expression related to the proteasomal degradation pathway.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbamcr.2010.05.002

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TPA inhibits TGF-β1-induced apoptosis down-regulating PDCD4 expression but does not stimulate phosphorylation of Akt and S6K1.

    “TPA also inhibits the TGF-β1-induced apoptosis down-regulating PDCD4 expression but does not stimulate the phosphorylation of Akt and S6K1.”

    From Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions (2019) · cites this paper as [68]

    Section 3.1 reports that TPA reduced TGF-β1-induced apoptosis and PDCD4 protein expression in Huh7 cells. But Section 3.2 (Fig. 3C) says TPA slightly stimulated phosphorylation of both Akt and S6K, contrary to the claim that it did not stimulate them. (LLM, conf=0.90)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • PRCKδ and PRCKε knockdown up-regulated PDCD4 expression, but PRCKα knockdown did not change PDCD4 expression.

    “siRNA-mediated knockdown of the PRCKs showed that PRCKδ and PRCKε knockdown up-regulated, but PRCKα did not change PDCD4 expression [68].”
  • The mTOR inhibitor rapamycin does not inhibit TPA-induced PDCD4 suppression in Huh7 hepatoma cells.

    “The mTOR inhibitor rapamycin does not inhibit the TPA-induced PDCD4 suppression in Huh7 hepatoma cells [68] (Figure 5).”
  • EGF and TPA suppress PDCD4 protein levels through different signaling pathways in Huh7 cells.

    “From these results, it was concluded that EGF and TPA suppress PDCD4-protein levels through different signaling pathways in Huh7 cells.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 51 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Nakashima, M., Hamajima, H., Xia, J., Iwane, S., Kwaguchi, Y., Eguchi, Y., Mizuta, T., Fujimoto, K., Ozaki, I., & Matsuhashi, S.
Affiliations
Saga University (JP)
Corresponding author
Ozaki, Iwata
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Publisher
Elsevier BV
Published
2010-09
Volume
1803
Issue
9
Pages
1020-1027
ISSN
0167-4889 (ISSN-L)
OpenAlex
W2042697056
Cited by
17
References
51
Citations by year
2025: 3 · 2021: 1 · 2020: 2 · 2019: 1 · 2016: 1 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 2
FWCI
0.78
Type
journal article
Language
en
Open access
Locations
  • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
PDCD4, PKC isoforms, PKCδ, protein kinase C epsilon, TGF-β1, apoptosis, Smad signaling, hepatoma cells, tissue plasminogen activator, proteasomal degradation, protein stability, tumor suppressor regulation
MeSH terms
Enzyme Inhibitors, Humans, Isoenzymes, Protein Kinase C, Tetradecanoylphorbol Acetate, Signal Transduction, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Genes, Tumor Suppressor, RNA-Binding Proteins, Phosphatidylinositol 3-Kinases, RNA, Small Interfering, Cell Line, Tumor, Proteasome Endopeptidase Complex, Cell Proliferation, Apoptosis Regulatory Proteins, Proto-Oncogene Proteins c-akt, Transforming Growth Factor beta1, Proteasome Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review